Daly, James L. http://orcid.org/0000-0002-4551-1256
Danson, Chris M.
Lewis, Philip A. http://orcid.org/0000-0002-2868-2459
Zhao, Lu
Riccardo, Sara
Di Filippo, Lucio
Cacchiarelli, Davide http://orcid.org/0000-0002-9621-6716
Lee, Daehoon
Cross, Stephen J. http://orcid.org/0000-0003-3565-0479
Heesom, Kate J. http://orcid.org/0000-0002-5418-5392
Xiong, Wen-Cheng http://orcid.org/0000-0001-9071-7598
Ballabio, Andrea http://orcid.org/0000-0003-1381-4604
Edgar, James R. http://orcid.org/0000-0001-7903-8199
Cullen, Peter J. http://orcid.org/0000-0002-9070-8349
Funding for this research was provided by:
Wellcome Trust (104568/Z/14/Z, 220260/Z/20/Z, 203959/Z/16/Z, 225128/Z/22/Z)
RCUK | Medical Research Council (MR/L007363/1, MR/P018807/1)
Royal Society (RSRP/R1/211004)
Article History
Received: 8 September 2022
Accepted: 5 May 2023
First Online: 29 May 2023
Competing interests
: A.B. is cofounder of CASMA Therapeutics and Advisory board member of Avilar Therapeutics and Coave Therapeutics. D.C. and A.B. are founders, shareholders, and consultants of Next Generation Diagnostic srl. S.R .and L.D.F. are employees of Next Generation Diagnostic srl. The remaining authors declare no competing interests.